Global Acute Ischemic Stroke Diagnosis and Treatment Market to Reach $2.4 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Acute Ischemic Stroke Diagnosis and Treatment estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$2.4 Billion by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027. Computed Tomography, one of the segments analyzed in the report, is projected to record a 4.2% CAGR and reach US$1.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Magnetic Resonance Imaging segment is readjusted to a revised 7.5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $502.4 Million, While China is Forecast to Grow at 4.6% CAGR
The Acute Ischemic Stroke Diagnosis and Treatment market in the U.S. is estimated at US$502.4 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$421.5 Million by the year 2027 trailing a CAGR of 4.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 3.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.Ultrasound Segment to Record 4% CAGR
In the global Ultrasound segment, USA, Canada, Japan, China and Europe will drive the 4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$90.8 Million in the year 2020 will reach a projected size of US$119.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.Select Competitors (Total 41 Featured) -
- Abbott Laboratories
- Bayer AG
- Biogen
- Boehringer Ingelheim
- Boston Scientific Corporation
- Cordis Corporation
- Covidien plc
- Daiichi Sankyo
- GE Healthcare
- Genentech, Inc.
- Hitachi Ltd
- Johnson & Johnson
- Koninklijke Philips N.V.
- Medtronic plc
- Merck & Co., Inc.
- Penumbra, Inc
- Pfizer Inc.
- Philips Healthcare
- Sanofi
- Siemens AG
- Siemens Healthcare
- Stryker Corporation
What's New for 2022?
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Frequently Asked Questions about the Global Market for Acute Ischemic Stroke Diagnosis and Treatment
What is the estimated value of the Global Market for Acute Ischemic Stroke Diagnosis and Treatment?
The Global Market for Acute Ischemic Stroke Diagnosis and Treatment was estimated to be valued at $1.7 Billion in 2020.
What is the growth rate of the Global Market for Acute Ischemic Stroke Diagnosis and Treatment?
The growth rate of the Global Market for Acute Ischemic Stroke Diagnosis and Treatment is 5.0%, with an estimated value of $2.4 Billion by 2027.
What is the forecasted size of the Global Market for Acute Ischemic Stroke Diagnosis and Treatment?
The Global Market for Acute Ischemic Stroke Diagnosis and Treatment is estimated to be worth $2.4 Billion by 2027.
Who are the key companies in the Global Market for Acute Ischemic Stroke Diagnosis and Treatment?
Key companies in the Global Market for Acute Ischemic Stroke Diagnosis and Treatment include Abbott Laboratories, Bayer AG, Biogen, Boehringer Ingelheim, Boston Scientific Corporation, Cordis Corporation, Covidien plc, Daiichi Sankyo and Genentech, Inc..
| Report Attribute | Details |
|---|---|
| No. of Pages | 194 |
| Published | October 2022 |
| Forecast Period | 2020 - 2027 |
| Estimated Market Value ( USD | $ 1.7 Billion |
| Forecasted Market Value ( USD | $ 2.4 Billion |
| Compound Annual Growth Rate | 5.0% |
| Regions Covered | Global |
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Acute Ischemic Stroke Diagnosis and Treatment - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 2: World Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 3: World 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
- Table 4: World Recent Past, Current & Future Analysis for Computed Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 5: World Historic Review for Computed Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 6: World 15-Year Perspective for Computed Tomography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
- Table 7: World Recent Past, Current & Future Analysis for Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 8: World Historic Review for Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 9: World 15-Year Perspective for Magnetic Resonance Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
- Table 10: World Recent Past, Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 11: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 12: World 15-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
- Table 13: World Recent Past, Current & Future Analysis for Cerebral angiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 14: World Historic Review for Cerebral angiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 15: World 15-Year Perspective for Cerebral angiography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
- Table 16: World Recent Past, Current & Future Analysis for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 17: World Historic Review for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 18: World 15-Year Perspective for Nuclear Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
- Table 19: World Recent Past, Current & Future Analysis for Other Diagnostic Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 20: World Historic Review for Other Diagnostic Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 21: World 15-Year Perspective for Other Diagnostic Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
- Table 22: World Recent Past, Current & Future Analysis for Carotid Endarterectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 23: World Historic Review for Carotid Endarterectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 24: World 15-Year Perspective for Carotid Endarterectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
- Table 25: World Recent Past, Current & Future Analysis for Angioplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 26: World Historic Review for Angioplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 27: World 15-Year Perspective for Angioplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
- Table 28: World Recent Past, Current & Future Analysis for Endovascular Mechanical Thrombectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 29: World Historic Review for Endovascular Mechanical Thrombectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 30: World 15-Year Perspective for Endovascular Mechanical Thrombectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
- Table 31: World Acute Ischemic Stroke Diagnosis and Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027
UNITED STATES
- Acute Ischemic Stroke Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
- Table 32: USA Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 33: USA Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 34: USA 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2021 & 2027
- Table 35: USA Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 36: USA Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 37: USA 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2021 & 2027
CANADA
- Table 38: Canada Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 39: Canada Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 40: Canada 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2021 & 2027
- Table 41: Canada Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 42: Canada Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 43: Canada 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2021 & 2027
JAPAN
- Acute Ischemic Stroke Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
- Table 44: Japan Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 45: Japan Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 46: Japan 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2021 & 2027
- Table 47: Japan Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 48: Japan Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 49: Japan 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2021 & 2027
CHINA
- Acute Ischemic Stroke Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
- Table 50: China Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 51: China Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 52: China 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2021 & 2027
- Table 53: China Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 54: China Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 55: China 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2021 & 2027
EUROPE
- Acute Ischemic Stroke Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
- Table 56: Europe Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 57: Europe Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 58: Europe 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
- Table 59: Europe Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 60: Europe Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 61: Europe 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2021 & 2027
- Table 62: Europe Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 63: Europe Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 64: Europe 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2021 & 2027
FRANCE
- Acute Ischemic Stroke Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
- Table 65: France Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 66: France Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 67: France 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2021 & 2027
- Table 68: France Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 69: France Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 70: France 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2021 & 2027
GERMANY
- Acute Ischemic Stroke Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
- Table 71: Germany Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 72: Germany Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 73: Germany 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2021 & 2027
- Table 74: Germany Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 75: Germany Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 76: Germany 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2021 & 2027
ITALY
- Table 77: Italy Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 78: Italy Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 79: Italy 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2021 & 2027
- Table 80: Italy Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 81: Italy Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 82: Italy 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2021 & 2027
UNITED KINGDOM
- Acute Ischemic Stroke Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
- Table 83: UK Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 84: UK Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 85: UK 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2021 & 2027
- Table 86: UK Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 87: UK Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 88: UK 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2021 & 2027
REST OF EUROPE
- Table 89: Rest of Europe Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 90: Rest of Europe Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 91: Rest of Europe 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2021 & 2027
- Table 92: Rest of Europe Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 93: Rest of Europe Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 94: Rest of Europe 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2021 & 2027
ASIA-PACIFIC
- Acute Ischemic Stroke Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
- Table 95: Asia-Pacific Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 96: Asia-Pacific Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 97: Asia-Pacific 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Diagnostic Type - Percentage Breakdown of Value Sales for Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography, Nuclear Imaging and Other Diagnostic Types for the Years 2012, 2021 & 2027
- Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 99: Asia-Pacific Historic Review for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 100: Asia-Pacific 15-Year Perspective for Acute Ischemic Stroke Diagnosis and Treatment by Surgery Type - Percentage Breakdown of Value Sales for Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy for the Years 2012, 2021 & 2027
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Laboratories
- Bayer AG
- Biogen
- Boehringer Ingelheim
- Boston Scientific Corporation
- Cordis Corporation
- Covidien plc
- Daiichi Sankyo
- GE Healthcare
- Genentech, Inc.
- Hitachi Ltd
- Johnson & Johnson
- Koninklijke Philips N.V.
- Medtronic plc
- Merck & Co., Inc.
- Penumbra, Inc
- Pfizer Inc.
- Philips Healthcare
- Sanofi
- Siemens AG
- Siemens Healthcare
- Stryker Corporation
